Preparing for widespread use of biomarkers to diagnose Alzheimer’s disease

For years, many people with Alzheimer’s disease have been diagnosed clinically and confirmed at autopsy. Now Alzheimer’s disease pathology can be identified with relatively high accuracy via a blood test that has the potential for widespread use in practice.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup